Jasper is one of the consultants at the Iperion Consultancy firm specialized in the implementation of IDMP and XEVMPD at pharmaceutical companies. He has worked on these topics since 2012 from start to finish as a business architect, including activities such as data collection and quality control, system requirements specification and implementation, procedure creation and data migration projects. Jasper has a background in chemistry and innovation management, and he enjoys solving the puzzles imposed by these new requirements and regulations.

Frits Stulp is Managing Director of Iperion a Deloitte business, with over 20 years of industry and consultancy experience. In this role he leads a team of regulatory / IDMP experts active in various projects to deliver value to both pharmaceutical companies as well as regulators. Frits is the IDMP topic group lead for the IRISS Forum and heavily involved in the EU-SRS project for the Medicines Evaluation Board / European Medicines Agency as part of SPOR landscape. Frits is also Chariman of the Board of CTADHL, involved in Transatlantic adoption of IDMP (www.ctadhl.org). Regarded as an SME on IDMP, he gladly shares his gained knowledge and experience in various occasions around the globe.